Munsch Frederick sold $2.3M of BLCO
Munsch Frederick (SVP, Controller and CAO) sold 112,015 shares of Bausch & Lomb Corp (BLCO) at $20.48 ($2.29M total) on 2026-10-29.
How this was made
The 30-second read
Why it matters
The disclosed sale reduces insider ownership and may be interpreted as a lack of confidence, potentially prompting short‑term price weakness.
Market read
Primary insider sale; modest materiality for traders monitoring BLCO.
What to watch
No 10b5‑1 plan was in place, suggesting the timing may be discretionary.
Background
SEC Form 4 insider transaction filed on 2026‑11‑02 for Bausch & Lomb Corp (BLCO).
Ticker impact
Form 4 shows SVP Frederick Munsch sold 112,015 shares for $2.29 M, reducing his stake to 45,831 shares.
likely downward pressure as the market prices the insider sell
A $2.3 M sale by a senior officer is material for a mid‑cap health‑care company and often triggers short‑term selling.
Market effects
Minimal; the sale is company‑specific and does not affect the broader ophthalmic‑devices sector.
None; the filing is U.S.‑focused.
Low; only relevant to investors in BLCO.
Counterpoint
The sale could be a routine portfolio rebalancing rather than a negative signal.
Key entities
- companyBausch & Lomb Corp
US‑listed ophthalmic‑devices manufacturer (ticker BLCO).
- personFrederick Munsch
SVP, Controller and CAO of Bausch & Lomb; insider seller.
